Public-registry site landscape for NCT05312567, a Vasomotor Symptoms study sponsored by Fervent Pharmaceuticals. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT05312567 (registry record) |
| Sponsor | Fervent Pharmaceuticals |
| Condition(s) | Vasomotor Symptoms; Menopause |
| Phase | PHASE2 |
| Listed sites | 12 |
| Site countries | United States |
Eichor generates a preliminary site-risk snapshot for NCT05312567 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →